• OPEN AN ACCOUNT
Indian Indices
Sensex
76,835.78 776.01
( 1.02%)
Global Indices
Nasdaq
51,969.87 237.22
(0.46%)
Dow Jones
7,434.30 5.00
(0.07%)
Hang Seng
64,889.11 277.96
(0.43%)
Nikkei 225
10,738.51 99.34
(0.93%)
Forex
USD-INR
96.67 0.19
(0.20%)
EUR-INR
110.18 0.12
(0.10%)
GBP-INR
129.04 -0.01
(0.00%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
34.32
847.98
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.07
 

yaan enterprises ltd
Kotak Mahindra Bank executes BTA with Deutsche Bank AG
Jun 30,2026

Kotak Mahindra Bank has executed a business transfer agreement with Deutsche Bank Aktiengesellschaft (acting through its branch in India) (DBAG) (BTA) on 30 June 2026 for the acquisition of DBAG's retail banking, private banking and wealth management business in India (Business Undertaking) as a going concern on a slump sale basis, subject to requisite approvals and the fulfilment of conditions specified in the BTA.

Kotak Mahindra Asset Management Company (Kotak AMC) and Kotak Alternate Asset Managers (KAAML) (both being wholly owned subsidiaries of Kotak Bank) have entered into non-binding term sheets with Deutsche Investments India (DIIPL) (which is a subsidiary of DBAG) for referral of clients for Portfolio Management Services and Investment Advisory, respectively. This remains subject to the definitive agreements to be entered into in this regard by DIIPL with Kotak AMC and KAAML, respectively. Kotak Bank will make relevant disclosure(s) upon signing of such definitive agreements.